This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Despite a high prevalence of childhood and youth-aged obesity, the use of medications for treating obesity is persistently low among children and young adults (YA), according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. Accessed June 25, 2025.
This schedule also helped dictate insurancecoverage of those recommended vaccines. CDC Report Finds No Connection Between Thimerosal and Autism Ashley Gallagher June 25th 2025 Article Thimerosal is a mercury-containing compound that has been widely used as a preservative in some biological and drug products since the 1930s.
She warned that changes in vaccine recommendations could impact insurancecoverage, patient access, and ultimately public health, particularly for vulnerable populations like low-income children.
Although one may seem more expensive than the other, your out-of-pocket cost can depend on several factors, such as your location, choice of pharmacy, and insurancecoverage. In 2025, it was also approved to reduce the risk of worsening kidney problems, such as kidney failure, in people with Type 2 diabetes and chronic kidney disease.
Insurance often does come through if the prescription is for diabetes management, not weight loss. However, insurancecoverage depends on the insurance company and plan. That’s because insurancecoverage varies by plan. Some Aetna enrollees receive coverage for Mounjaro. Does Aetna cover Mounjaro?
Investigators find that current practices among pharmacists are not fully in alignment with American Diabetes Association (ADA) guideline recommendations for glucagon use, with frequently identified barriers including cost, patient health literacy, and insurancecoverage. June 20 to 23, 2025. Chicago, Illinois.
Aside from disparities in HbA1c and overall CGM use, researchers uncovered inequities in CGM wear time and access, according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. Among those with T1D, at least 40% are using CGMs.
Because it costs over $550 per month on average for 30, 30 mg capsules of Vyvanse, insurancecoverage is often relied upon to make it more affordable. However, coverage varies by plan and may depend on various factors. Here’s what to know about United Healthcare’s coverage of Vyvanse. You have to choose one or the other.
True visibility comes from layering pharmacy locations on top of geospatial data, such as population density, income levels, transportation access, insurancecoverage, and health burden. Image Maggie McCullough 12 June, 2025 pharmacy deserts Bookmark this Oncology ImmunityBio’s ANKTIVA & FDA Expanded Access: Transforming bl.
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.
Without insurancecoverage or other financial assistance, Rexulti can be fairly pricey, which might leave uninsured or underinsured patients looking for help. If you waltz into a pharmacy to pick up your Rexulti prescription—no insurancecoverage, coupons, discounts, or other savings—you could pay around $2,025 for 30, 1 mg tablets.
New changes to Medicare in 2025 Medicare is a federal health insurance program developed for people 65 and older and younger individuals with certain disabilities. It provides access to hospital care, medical services, and prescription drug coverage. This continues until your total drug costs reach $2,000 in 2025.
Medicare coverage of Vraylar falls under Medicare Part D prescription drug coverage, and understanding how much you’ll pay for Vraylar with Medicare can be a little confusing. On top of that, Part D is undergoing changes in 2025 that will reduce drug costs for Medicare users, so that will also affect your costs moving forward.
In other words, coverage for this brand-name medication is not assured. Aetnas 2025 Standard Plan , for example, does not cover Cequa. Consult your formulary to determine coverage, and then, check to see what your copay amounts to if it is covered.
However, Mounjaro isnt listed on the 2025 Medicare Part D Formulary for Kaiser , so you may have to call your plan administrator for verification. Pay attention to details about coverage levels and any specific requirements or restrictions.
We spot-checked the drug lists of eight BCBS affiliates around the country, and only a couple of the Blue Cross Blue Shield plans we looked at have Zepbound on their formularies, and certain criteria must be met in order to receive and maintain insurancecoverage. Without insurance, Zepbound costs an average of $1,524 for 4, 0.5
June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Growing interest in SDoH aligns with the rising use of RWD, which offers valuable insights into diverse populations. Dedicated datasets highlight those differences to help improve overall standards of care. Login Registration is disabled.
in 2027 and other countries in 2025, when a generic version may be approved. Is Nexplanon covered by insurance? Most insurance companies offer health insurance plans that cover Nexplanon and other birth control methods. How much does Nexplanon cost without insurance? Here are some potential strategies: 1.
James Kirby, PharmD, BCPS, FAPhA, is PQAs Board Chair for 2025. If I look at what we aimed to accomplish under the 2025 plan, it makes me very proud to be part of PQA. Theirexpertisehelps PQA advance the safe andappropriate useof medicines. This blog is one in aseries profiling PQA's Board members.
While Lumigan is a 0.01% solution of bimatoprost and no generic product is manufactured at this concentration, patents on Lumigan expire in 2025 and 2027, so there may be a generic option approved by the Food and Drug Administration (FDA) thereafter. Is Lumigan covered by insurance? Bimatoprost is the generic name for Lumigan.
Unfortunately, there are no generic versions of extended-release memantine/donepezil, and there won’t be until 2025. Medicaid coverage will depend on the state or the formularies of individual managed Medicaid plans. How much does Namzaric cost without insurance?
According to the 2025 Medicaid Drug Formulary for the Neighborhood Health Plan of Rhode Island, Linzess is considered a Tier 2 drug, which is categorized similarly to Tier 3 Medicare drugs. However, your insurance company may recommend trying a cheaper alternative before covering Linzess, which will be covered in a later section.
Goldman and Isaacs emphasize the importance of identifying at-risk patients through various health care touchpoints, including doctor's offices and pharmacies, and advocate for routine glucagon prescription and insurancecoverage.
Source: ADA, 2025 Type 2 diabetes Type 2 diabetes accounts for about 94% of diabetes cases in adults in the U.S. ADA, 2025) Men are slightly more likely than women to be diagnosed with Type 2 diabetes. ADA, 2025) Men are slightly more likely than women to be diagnosed with Type 2 diabetes. From 2017 to 2018, an estimated 2.2%
Sayer primarily focuses on barriers to insurancecoverage and the need for educational efforts among health care providers and patients. That'll all be fully implemented by the end of 2025. We are getting insurancecoverage. We've had major wins this year. It takes a while to implement things like that.
They highlighted that only 4% of the 15 million people using insulin have a glucagon prescription, largely due to misconceptions about ease of use, cost, and insurancecoverage. Goldman and Isaacs discussed the significant barriers to glucagon prescription and utilization for individuals with diabetes. Subscribe Now!
Glucagon Prescribing Not in Full Alignment With ADA Guidelines | ADA 2025 Ashley Gallagher June 25th 2025 Article The most frequent barriers to access to glucagon include cost, patient health literacy, and insurancecoverage.
A monthly supply of Wegovy can cost more than $1,800 without insurance. However, growing insurancecoverage and savings programs are helping to make it more accessible. A study published in 2025 reported that Wegovy was prescribed about 428,000 times in February 2024. How many Americans use insurance for Wegovy?
The best way to determine the cost without insurance is to look at the prices of these brand-name drugs. Even then, each patient’s out-of-pocket cost may vary by pharmacy, insurancecoverage, and pharmacy location: The average retail price for a one-month supply of Mounjaro is $1,493. Does insurance cover tirzepatide?
24 Hours in the Hub Still Matters More June 16, 2025 By Chris Dowd, ConnectiveRx Commentary Article Pharmaceutical Commerce Pharmaceutical Commerce - June 2025 Volume 20 Issue 3 Doubling down on patient access and support fundamentals will win out over Washington’s next move. Chris Dowd Key Takeaways Speed is Critical.
The cost of semaglutide can vary on whether youre getting a brand-name or compounded version and whether you have insurancecoverage. A monthly supply of semaglutide ranges from about $129$1,850 without insurance. Is semaglutide covered by insurance? For those licensed by the state, the deadline is April 22, 2025.
Coverage of Paxlovid by insurance plans is unpredictable and differs from one plan to another. For example, in 2025, Aetnas Standard Plan and Humanas Medicare Advantage Plan include Paxlovid in their formularies. The first step is determining whether it is on your plans drug formulary.
Those patients would lose insurancecoverage/access to those products, but the PBM was contractually obligated to keep the product on formulary for the other 85% of lives. As of Q2 2025, Daraprim remains priced at $750 under its current manufacturer. Some companies saw this as a winning commercial decision.
WASHINGTON — President Biden on Monday unveiled his requests for the 2025 budget, potentially his last chance to cement a legacy on drug costs, cancer research, and broad health care coverage. The president’s $130.7 billion proposal is a dip from the $144.3 Continue to STAT+ to read the full story…
Overcoming Cancer Care Disparities TexasOncology's Susan Escudierdiscussedthe impact of insurancecoverage gaps, transportation barriers, and financial hardships on cancer care access and emphasizes the need for payers to better support patients at high risk. Selected participants will be notified by March 21, 2025.Individuals
But despite its popularity, Ozempics insurancecoverage isnt universal, leaving many people with Kaiser Permanente plans wondering if theyll receive coverage. In many cases, insurance and Medicare plans will cover Ozempic, but there are many variables at play, including the specific insurance plan and why its prescribed.
Image Phil Taylor 7 July, 2025 Prostate cancer Bookmark this News Trump signs Medicaid-slashing budget into law Trumps One Big Beautiful Bill Act is signed into law, and commentators are gauging its impact on healthcare insurancecoverage. Oncology In pursuit of a cure for cancer: An ASCO 2025 discussion wit.
Democrats have campaigned heavily against the Project 2025 agenda put out by a conservative think tank, despite Trump insisting he does not endorse the blueprint.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content